Compumedics News

News

Ticker

CMP.AX

ISIN

AU000000CMP2

Inntekter Nettoinntekt P/E P/S EBIT Dividende Innsiderkjøp Aksjer Markedsverdi Gjeld Forpliktelser Egenkapital AAQS Ansatte ROE ROA ROCE News Dokumenter

Compumedics Eulerpool Nyheter

Compumedics aksjenyheter

Compumedics blir overvåket av journalister og investorer verden over. Vi samler de seneste Compumedics nyhetene her.

15. mai·
Yahoo
Compumedics Achieves World-First Adult and Child Optimized Recordings from a Single MEG System
1. september·
Yahoo
Compumedics Full Year 2024 Earnings: AU$0.001 loss per share (vs AU$0.035 loss in FY 2023)

Compumedics aksjesaksmeldinger

Compumedics publiserer regelmessig nyheter på selskapets nettsted som er relevante for investorer.

Compumedics News 2026

Denne siden inneholder alle aktuelle nyheter, analyser og pressemeldinger for Compumedics aksje (CMP.AX, ISIN: AU000000CMP2). Dette inkluderer Eulerpool-nyheter, selskapets analyser og offisielle pressemeldinger. Data oppdateres regelmessig for å gi investorer en fullstendig oversikt over de seneste utviklingene hos Compumedics.

Compumedics Aksje

Compumedics Compumedics Ltd., headquartered in Melbourne, Australia, operates in the Health Care sector, specializing in the research, development, manufacture, and distribution of medical equipment. The company employs 135 full-time staff and serves global markets across the Americas, Australia, Asia Pacific, and Europe and the Middle East. Its product portfolio includes sleep diagnostic systems, clinical EEG systems, brain monitoring solutions, ultrasonic blood-flow systems, and technical support services. Key offerings encompass Somfit/Somfit Pro, Grael 4K PSG:EEG, and Compumedics Neuroscan for neurology applications and brain research technologies.